TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2023

Poziotinib in Treatment-Naive NSCLC Harboring HER2 Exon 20 Mutations: ZENITH20-4, A Multicenter, Multicohort, Open-Label, Phase 2 Trial (Cohort 4).

Robin Cornelissen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.